Search for Clinical Trial Results

Sponsored By

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - 25 Studies Found

Status Study
Completed Study Name: 506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL)
Condition: T-ALL, T-NHL (Lymphoblastic)
Date: 2008-05-16
Interventions: Drug: Nelarabine 1500 mg/m² i.v., duration 2 hrs, day 1, 3, 5
Completed Study Name: Hyper-CVAD Treatment of Adult T-cell Acute Lymphoblastic Leukemia in Sweden.
Condition: T-cell Acute Lymphoblastic Leukemia
Date: 2013-09-07
Recruiting Study Name: A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL
Condition:
  • T-cell Acute Lymphoblastic Leukemia
  • T-cell Lymphoblastic Lympho
    Date: 2015-08-05
    Interventions:
    • Drug: LY3039478 Administered o
Terminated Study Name: Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Condition:
  • Relapsed T-Cell Acute Lymphoblastic Leukemia
  • Relapsed T-Cell Ly
    Date: 2009-09-09
    Interventions:
    • Drug: Nelarabine Dose will be

Active, not recruiting Study Name: Evaluation and Treatment of Tall Statured Girls
Condition: Constitutional Tall Stature
Date: 2015-12-13
Interventions: Drug: Estradiol Estradiol containing compounds administered orally in a non-randomized manner.
Recruiting Study Name: BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma
Condition:
  • T-Acute Lymphoblastic Leukemia
  • Adult T Lymphoblastic Lymphoma Date: 2016-05-03
    Interventions:
    • Drug: BL-8040
    • Drug: Nelarabine

Active, not recruiting Study Name: Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Condition:
  • Lymphoblastic Leukemia, Acute T-cell
  • Precursor T-Cell Lymphoblastic Ly
    Date: 2011-04-22
    Interventions:
    • Drug: BMS-906024 Other Name: N
Recruiting Study Name: Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia
Condition: T-cell Type Acute Leukemia-Precursor T-lymphoblastic Lymphoma/Leukaemia
Date: 2016-12-19
Interventions:
  • Drug: Isatuximab SAR650984 Pha
Recruiting Study Name: Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
Condition:
  • Adult T Acute Lymphoblastic Leukemia
  • Childhood
  • Drug: Bortezomib Given IV
Active, not recruiting Study Name: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Condition:
  • Adult T Acute Lymphoblastic Leukemia
  • Childhood
  • Drug: Asparaginase Given IM or
Next >>>